SCARTEC THERAPEUTICS
ScarTec Therapeutics develops novel peptide-based technology for scar-free healing.
SCARTEC THERAPEUTICS
Industry:
Biotechnology Medical
Founded:
2016-01-01
Address:
Enschede, Overijssel, The Netherlands
Country:
The Netherlands
Total Employee:
1+
Status:
Active
Total Funding:
71.43 K EUR
Similar Organizations
Feldan Therapeutics
Feldan Therapeutics has developed a patented peptide-based technology platform.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - ScarTec Therapeutics
More informations about "ScarTec Therapeutics"
ScarTec Therapeutics | Advanced Organ bioengineering and …
ScarTec Therapeutics is a biotech company developing novel therapeutics against clinical indications with unmet clinical needs, mainly focused on fibrosis and tumor stroma. ScarTec …See details»
ScarTec Therapeutics - Google Sites
ScarTec Therapeutics. Overcoming Barriers in Cancer Therapy ... Scartec has developed a proprietary platform to identify novel targets that can stop the activation of cancer-associated …See details»
ScarTec Therapeutics - Company Profile - Tracxn
Sep 14, 2024 ScarTec Therapeutics ranks 1,638th among 2366 active competitors. 854 of its competitors are funded while 545 have exited. Overall, ScarTec Therapeutics and its …See details»
ScarTec Therapeutics B.V. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ScarTec Therapeutics B.V. of Enschede, Overijssel. Get the latest business insights from Dun & …See details»
ScarTec Therapeutics - LinkedIn
ScarTec Therapeutics | 15 followers on LinkedIn. Developing innovative therapeutics against fibrotic diseases and cancer.See details»
ScarTec Therapeutics - Raised Funding from 2 investors - Tracxn
4 days ago ScarTec Therapeutics has raised funding over 2 rounds from 2 investors. Investors include European Union and EIC Fund. Their latest funding round was of $55.7K on May 31, …See details»
SCARTEC THERAPEUTICS BV - VentureRadar
Dec 1, 2018 Title: Advancing a novel peptide-based therapeutic for pancreatic cancer (Acronym: FIBROHALT) | Total Cost: €71429 / EU contribution: €50000 | Start: 2018-12-01 End: 2019-05-31See details»
Scartec Therapeutics Bv - DevelopmentAid
Scartec Therapeutics Bv — Consulting Organization, Engineering Firm from the Netherlands, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Science & Innovation sectorsSee details»
ScarTec Therapeutics - Crunchbase
ScarTec Therapeutics develops novel peptide-based technology for scar-free healing.See details»
ScarTec Therapeutics BV - Drug pipelines, Patents, Clinical trials ...
Nov 1, 2024 100 Translational Medicine associated with ScarTec Therapeutics BV. Login to view more data. Corporation Tree. Boost your research with our corporation tree data. login. or. …See details»
ScarTec Therapeutics BV
Everyone deserves a fresh start. About usSee details»
Grant - ScarTec Therapeutics - 2019-01-01 - Crunchbase
Organization Name . ScarTec Therapeutics . Announced Date Jan 1, 2019; Funding Type ...See details»
prof.dr. J. Prakash (Jai) - Universiteit Twente
Based on my inventions, I have founded a spin-off company ScarTec Therapeutics, which is developing novel peptide therapeutics for the treatment of organ fibrosis and tumor stroma. …See details»
ScarTec Therapeutics founders & board of directors - Tracxn
Nov 5, 2024 Jai Prakash, Founder & Managing Director at . ScarTec TherapeuticsView all ScarTec Therapeutics Founders About the team at ScarTec Therapeutics?Jai Prakash, …See details»
New drug may enhance efficacy of chemotherapy in pancreatic …
Sep 5, 2019 Jai Prakash patented the peptide and started a company called ScarTec Therapeutics, with Dutch Research Council (NWO-TTW) and EU support, for accelerating the …See details»
ScarTec Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 1, 2019: Grant - ScarTec …See details»
Jai Prakash bio - BNLF-crs
Jai Prakash is a Professor (adjunct) and Head of Targeted Therapeutics at the Technical Medical Centre, University of Twente (Netherlands). His current research focus is to design novel …See details»
ScarTec Therapeutics - Tech Stack, Apps, Patents & Trademarks
Nov 10, 2024 Organization. ScarTec Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech …See details»
Stoke Therapeutics Receives FDA Breakthrough Therapy ... - Nasdaq
4 days ago Stoke Therapeutics, Inc., a biotechnology company dedicated to restoring protein expression by harnessing the body’ s potential with RNA medicine, today announced that it …See details»
ScarTec Therapeutics - Contacts, Employees, Board Members
Organization. ScarTec Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. …See details»